Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease

被引:28
作者
Takahashi, M [1 ]
Iseki, E [1 ]
Kosaka, K [1 ]
机构
[1] Yokohama City Univ, Sch Med, Dept Psychiat, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
关键词
Lewy body; dementia with Lewy bodies; diffuse Lewy body disease; cyclin-dependent kinase 5; immunohistochemistry;
D O I
10.1016/S0006-8993(00)02086-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated the cyclin-dependent kinase (Cdk) 5 distribution pattern in diffuse Lewy body disease brains using immunohistochemistry. Cdk5 immunoreactivity was detected in both brainstem-type Lewy bodies (LBs) and cortical LBs. The number of Cdk5-positive LBs was less than that of ubiquitin- or alpha-synuclein-positive LBs, and more than that of phosphorylated neurofilament-positive LBs. Immunoelectron microscopy revealed Cdk5-immunolabeled granulo-filamentous components in LBs and LB-related neurites. These data suggest that Cdk5 may be associated with LB formation. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:253 / 256
页数:4
相关论文
共 16 条
[1]   Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Hirai, S ;
Izumiyama, Y ;
Tonozuka-Uehara, H ;
Kawai, M .
BRAIN RESEARCH, 1998, 808 (01) :93-100
[2]  
BRION JP, 1995, AM J PATHOL, V147, P1465
[3]   Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18 [J].
Fletcher, AI ;
Shuang, RQ ;
Giovannucci, DR ;
Zhang, L ;
Bittner, MA ;
Stuenkel, EL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) :4027-4035
[4]   Cyclin-dependent protein kinase 5 activity increases in rat brain following ischemia [J].
Green, SL ;
Kulp, KS ;
Vulliet, R .
NEUROCHEMISTRY INTERNATIONAL, 1997, 31 (04) :617-623
[5]  
Hellström J, 1999, J COMP NEUROL, V411, P578
[6]   Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra [J].
Henchcliffe, C ;
Burke, RE .
NEUROSCIENCE LETTERS, 1997, 230 (01) :41-44
[7]   Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease [J].
Iseki, E ;
Marui, W ;
Kosaka, K ;
Akiyama, H ;
Ueda, K ;
Iwatsubo, T .
NEUROSCIENCE LETTERS, 1998, 258 (02) :81-84
[8]   DIFFUSE LEWY BODY DISEASE IN JAPAN [J].
KOSAKA, K .
JOURNAL OF NEUROLOGY, 1990, 237 (03) :197-204
[9]   LEWY BODIES ARE UBIQUITINATED - A LIGHT AND ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMICAL STUDY [J].
KUZUHARA, S ;
MORI, H ;
IZUMIYAMA, N ;
YOSHIMURA, M ;
IHARA, Y .
ACTA NEUROPATHOLOGICA, 1988, 75 (04) :345-353
[10]   Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop [J].
McKeith, IG ;
Galasko, D ;
Kosaka, K ;
Perry, EK ;
Dickson, DW ;
Hansen, LA ;
Salmon, DP ;
Lowe, J ;
MIrra, SS ;
Byrne, EJ ;
Lennox, G ;
Quinn, NP ;
Edwardson, JA ;
Ince, PG ;
Bergeron, C ;
Burns, A ;
Miller, BL ;
Lovestone, S ;
Collerton, D ;
Jansen, ENH ;
Ballard, C ;
deVos, RAI ;
Wilcock, GK ;
Jellinger, KA ;
Perry, RH .
NEUROLOGY, 1996, 47 (05) :1113-1124